ROCKWELL MEDICAL INC (RMTI) Stock Price & Overview

NASDAQ:RMTIUS7743743004

Current stock price

0.8961 USD
0 (-0.09%)
At close:
0.878 USD
-0.02 (-2.02%)
After Hours:

The current stock price of RMTI is 0.8961 USD. Today RMTI is down by -0.09%. In the past month the price decreased by -12.15%. In the past year, price decreased by -47.29%.

RMTI Key Statistics

52-Week Range0.7801 - 2.1
Current RMTI stock price positioned within its 52-week range.
1-Month Range0.8506 - 1.07
Current RMTI stock price positioned within its 1-month range.
Market Cap
35.315M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.16
Dividend Yield
N/A

RMTI Stock Performance

Today
-0.09%
1 Week
+3.45%
1 Month
-12.15%
3 Months
-3.10%
Longer-term
6 Months -44.69%
1 Year -47.29%
2 Years -46.02%
3 Years -50.49%
5 Years -92.98%
10 Years -98.92%

RMTI Stock Chart

ROCKWELL MEDICAL INC / RMTI Daily stock chart

RMTI Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to RMTI. When comparing the yearly performance of all stocks, RMTI is a bad performer in the overall market: 86.16% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

RMTI Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to RMTI. The financial health of RMTI is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

RMTI Earnings

On November 12, 2025 RMTI reported an EPS of -0.05 and a revenue of 15.93M. The company missed EPS expectations (-8.93% surprise) and missed revenue expectations (-3.86% surprise).

Next Earnings DateMar 26, 2026
Last Earnings DateNov 12, 2025
PeriodQ3 / 2025
EPS Reported-$0.05
Revenue Reported15.927M
EPS Surprise -8.93%
Revenue Surprise -3.86%

RMTI Forecast & Estimates

8 analysts have analysed RMTI and the average price target is 3.83 USD. This implies a price increase of 326.85% is expected in the next year compared to the current price of 0.8961.

For the next year, analysts expect an EPS growth of -458.57% and a revenue growth -30.84% for RMTI


Analysts
Analysts82.5
Price Target3.83 (327.41%)
EPS Next Y-458.57%
Revenue Next Year-30.84%

RMTI Groups

Sector & Classification

RMTI Financial Highlights

Over the last trailing twelve months RMTI reported a non-GAAP Earnings per Share(EPS) of -0.16. The EPS decreased by -213.73% compared to the year before.


Income Statements
Revenue(TTM)75.58M
Net Income(TTM)-5.52M
Industry RankSector Rank
PM (TTM) N/A
ROA -9.6%
ROE -14.9%
Debt/Equity 0.26
Chartmill High Growth Momentum
EPS Q2Q%-200%
Sales Q2Q%-43.75%
EPS 1Y (TTM)-213.73%
Revenue 1Y (TTM)-23.6%

RMTI Ownership

Ownership
Inst Owners8.92%
Shares39.41M
Float34.18M
Ins Owners4.19%
Short Float %2.39%
Short Ratio1.03

RMTI Competitors/Peers

The largest stocks on the US markets in the "Health Care Supplies" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
MDLN MEDLINE INC-CL A27.7853.953B
COO COOPER COS INC/THE13.9813.954B
ALGN ALIGN TECHNOLOGY INC14.2711.898B
SOLV SOLVENTUM CORP10.1611.471B
LNTH LANTHEUS HOLDINGS INC14.725.196B
MMSI MERIT MEDICAL SYSTEMS INC16.884.051B
ICUI ICU MEDICAL INC15.213.18B
HAE HAEMONETICS CORP/MASS11.152.764B
XRAY DENTSPLY SIRONA INC7.872.357B
NEOG NEOGEN CORP26.82.034B
UFPT UFP TECHNOLOGIES INC201.575B
STAA STAAR SURGICAL CO133.29914.719M
BVS BIOVENTUS INC - A11.04711.736M

About RMTI

Company Profile

RMTI logo image Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. The company is headquartered in Wixom, Michigan and currently employs 244 full-time employees. The firm develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. The firm operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The firm is the supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. The firm manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.

Company Info

IPO: 1998-01-27

ROCKWELL MEDICAL INC

30142 Wixom Road

Wixom MICHIGAN 48393 US

CEO: Russell Ellison

Employees: 244

RMTI Company Website

RMTI Investor Relations

Phone: 18004493353

ROCKWELL MEDICAL INC / RMTI FAQ

What does ROCKWELL MEDICAL INC do?

Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. The company is headquartered in Wixom, Michigan and currently employs 244 full-time employees. The firm develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. The firm operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The firm is the supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. The firm manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.


What is the stock price of ROCKWELL MEDICAL INC today?

The current stock price of RMTI is 0.8961 USD. The price decreased by -0.09% in the last trading session.


Does RMTI stock pay dividends?

RMTI does not pay a dividend.


What is the ChartMill technical and fundamental rating of RMTI stock?

RMTI has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Can you provide the sector and industry classification for ROCKWELL MEDICAL INC?

ROCKWELL MEDICAL INC (RMTI) operates in the Health Care sector and the Health Care Equipment & Supplies industry.


Can you provide the number of employees for ROCKWELL MEDICAL INC?

ROCKWELL MEDICAL INC (RMTI) currently has 244 employees.


When does ROCKWELL MEDICAL INC (RMTI) report earnings?

ROCKWELL MEDICAL INC (RMTI) will report earnings on 2026-03-26, after the market close.